Singapore markets open in 6 hours 17 minutes

ABBV Jan 2025 135.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
3.7800+0.9600 (+34.04%)
As of 02:44PM EDT. Market open.
Full screen
Previous close2.8200
Open3.7800
Bid3.8000
Ask3.9000
Strike135.00
Expiry date2025-01-17
Day's range3.7800 - 3.7800
Contract rangeN/A
Volume1
Open interest2.72k
  • Benzinga

    What's Going On AbbVie Stock On Friday?

    Friday, AbbVie Inc (NYSE:ABBV) released an interim analysis of an ongoing Phase 3, open-label 156-week extension study evaluating the long-term safety and tolerability of oral atogepant for the prevention of migraine in participants with chronic or episodic migraine. The shares are trading lower with a session volume of 3.9 million versus the average volume of 5.6 million, as per the data from Benzinga Pro. Also Read: AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue an

  • PR Newswire

    AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine

    AbbVie (NYSE: ABBV) today announced an interim analysis of an ongoing Phase 3, open-label 156-week extension study evaluating the long-term safety and tolerability of oral atogepant for the prevention of migraine in participants with chronic or episodic migraine. The overall long-term safety results were consistent with the known safety profile of atogepant in chronic and episodic migraine, and no new safety signals were identified. These results also support improvements in key efficacy outcome

  • Zacks

    AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors

    The latest trading day saw AbbVie (ABBV) settling at $167.52, representing a -0.89% change from its previous close.